Payment overview · 2025
General Payments
$17.63
1 reported records · 1 companies
Healthcare provider profile · identity verified
Nasreen Kango, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · TAKOMA PARK, MD · NPI 1154355345
Verified facts
What the public records show
CMS Open Payments records show Nasreen Kango, M.D. received $17.63 in general payments during 2025 across 1 reported records.
Sumitomo Pharma America, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Sumitomo Pharma America, Inc. | Unresolved — no canonical attribution shown | $17.63 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $17.63 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| GEMTESA Normalized: gemtesa |
Drug | Sumitomo Pharma America, Inc. | $17.63 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 614 | 193 |
| Amlodipine Besylate | Amlodipine Besylate | 441 | 135 |
| Levothyroxine Sodium | Levothyroxine Sodium | 252 | 70 |
| Metoprolol Succinate | Metoprolol Succinate | 243 | 71 |
| Losartan Potassium | Losartan Potassium | 223 | 76 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 211 | 86 |
| Metformin Hcl | Metformin Hcl | 197 | 59 |
| Pantoprazole Sodium | Pantoprazole Sodium | 177 | 60 |
| Lisinopril | Lisinopril | 167 | 55 |
| Hydrochlorothiazide | Hydrochlorothiazide | 154 | 44 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 147 | 55 |
| Gabapentin | Gabapentin | 141 | 62 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 135 | 47 |
| Furosemide | Furosemide | 132 | 45 |
| Meloxicam | Meloxicam | 118 | 45 |
| Famotidine | Famotidine | 114 | 49 |
| Ozempic | Semaglutide | 112 | 24 |
| Jardiance | Empagliflozin | 111 | 39 |
| Carvedilol | Carvedilol | 108 | 33 |
| Tamsulosin Hcl | Tamsulosin Hcl | 108 | 38 |
| Glimepiride | Glimepiride | 105 | 33 |
| Omeprazole | Omeprazole | 104 | 38 |
| Simvastatin | Simvastatin | 103 | 28 |
| Montelukast Sodium | Montelukast Sodium | 101 | 38 |
| Eliquis | Apixaban | 100 | 29 |
| Metoprolol Tartrate | Metoprolol Tartrate | 95 | 25 |
| Trazodone Hcl | Trazodone Hcl | 93 | 32 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 90 | 27 |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 86 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 85 | 15 |
| Clopidogrel | Clopidogrel Bisulfate | 84 | 27 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 83 | 20 |
| Fluticasone Propionate | Fluticasone Propionate | 76 | 38 |
| Duloxetine Hcl | Duloxetine Hcl | 75 | 31 |
| Metformin Hcl Er | Metformin Hcl | 74 | 26 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 74 | 13 |
| Allopurinol | Allopurinol | 72 | 26 |
| Atenolol | Atenolol | 70 | 17 |
| Azithromycin | Azithromycin | 69 | 54 |
| Escitalopram Oxalate | Escitalopram Oxalate | 68 | 22 |
| Ibuprofen | Ibuprofen | 68 | 29 |
| Diclofenac Sodium | Diclofenac Sodium | 64 | 32 |
| Azelastine Hcl | Azelastine Hcl | 63 | 26 |
| Prednisone | Prednisone | 62 | 23 |
| Ezetimibe | Ezetimibe | 60 | 20 |
| Januvia | Sitagliptin Phosphate | 59 | 13 |
| Xarelto | Rivaroxaban | 59 | 15 |
| Farxiga | Dapagliflozin Propanediol | 57 | 17 |
| Donepezil Hcl | Donepezil Hcl | 55 | 16 |
| Nifedipine Er | Nifedipine | 54 | 18 |
| Pravastatin Sodium | Pravastatin Sodium | 52 | 15 |
| Potassium Chloride | Potassium Chloride | 51 | 18 |
| Tramadol Hcl | Tramadol Hcl | 51 | 19 |
| Glycopyrrolate | Glycopyrrolate | 50 | suppressed |
| Ketoconazole | Ketoconazole | 49 | 35 |
| Alendronate Sodium | Alendronate Sodium | 48 | 17 |
| Clobetasol Propionate | Clobetasol Propionate | 48 | 24 |
| Hydralazine Hcl | Hydralazine Hcl | 43 | 17 |
| Calcitriol | Calcitriol | 41 | 13 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 41 | 14 |
| Spironolactone | Spironolactone | 39 | 19 |
| Trulicity | Dulaglutide | 39 | 14 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 38 | 17 |
| Fluconazole | Fluconazole | 38 | 19 |
| Finasteride | Finasteride | 37 | suppressed |
| Alprazolam | Alprazolam | 36 | 12 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 36 | 13 |
| Tradjenta | Linagliptin | 36 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 35 | 16 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 34 | 26 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 34 | 11 |
| Chlorthalidone | Chlorthalidone | 32 | 13 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 32 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 32 | 17 |
| Myrbetriq | Mirabegron | 32 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 32 | 16 |
| Quetiapine Fumarate | Quetiapine Fumarate | 32 | suppressed |
| Topiramate | Topiramate | 31 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 31 | 20 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 31 | 13 |
| Amoxicillin | Amoxicillin | 30 | 22 |
| Colchicine | Colchicine | 30 | 16 |
| Mirtazapine | Mirtazapine | 30 | 15 |
| Pioglitazone Hcl | Pioglitazone Hcl | 30 | suppressed |
| Bumetanide | Bumetanide | 29 | suppressed |
| Bupropion Xl | Bupropion Hcl | 29 | suppressed |
| Lactulose | Lactulose | 29 | 14 |
| Methylprednisolone | Methylprednisolone | 29 | 22 |
| Sertraline Hcl | Sertraline Hcl | 29 | suppressed |
| Clonazepam | Clonazepam | 27 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 27 | suppressed |
| Linzess | Linaclotide | 27 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 26 | 16 |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 26 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 25 | suppressed |
| Diazepam | Diazepam | 24 | suppressed |
| Levofloxacin | Levofloxacin | 24 | 11 |
| Memantine Hcl | Memantine Hcl | 24 | suppressed |
| Naproxen | Naproxen | 24 | 13 |
| Nystatin | Nystatin | 24 | 11 |
| Dicyclomine Hcl | Dicyclomine Hcl | 23 | 15 |
| Entresto | Sacubitril/Valsartan | 23 | suppressed |
| Pregabalin | Pregabalin | 23 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 23 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 22 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 21 | suppressed |
| Lorazepam | Lorazepam | 21 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 21 | 11 |
| Cefdinir | Cefdinir | 20 | 19 |
| Cefuroxime | Cefuroxime Axetil | 20 | 18 |
| Celecoxib | Celecoxib | 20 | 13 |
| Estradiol | Estradiol | 20 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 20 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 20 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 19 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 19 | 15 |
| Repaglinide | Repaglinide | 18 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 17 | suppressed |
| Carbamazepine | Carbamazepine | 17 | suppressed |
| Ondansetron Odt | Ondansetron | 17 | 13 |
| Solifenacin Succinate | Solifenacin Succinate | 17 | suppressed |
| Baclofen | Baclofen | 16 | suppressed |
| Folic Acid | Folic Acid | 16 | suppressed |
| Methocarbamol | Methocarbamol | 16 | 12 |
| Propranolol Hcl | Propranolol Hcl | 16 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 16 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 15 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 15 | 12 |
| Ipratropium Bromide | Ipratropium Bromide | 15 | suppressed |
| Irbesartan | Irbesartan | 15 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 15 | suppressed |
| Mounjaro | Tirzepatide | 15 | suppressed |
| Silver Sulfadiazine | Silver Sulfadiazine | 15 | 12 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 15 | suppressed |
| Lovastatin | Lovastatin | 14 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 14 | 13 |
| Procto-Med Hc | Hydrocortisone | 14 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 14 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 13 | suppressed |
| Dutasteride | Dutasteride | 13 | suppressed |
| Fenofibrate | Fenofibrate | 13 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 13 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 13 | 12 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 13 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 13 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 12 | suppressed |
| Desmopressin Acetate | Desmopressin Acetate | 12 | suppressed |
| Dupixent Pen | Dupilumab | 12 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 12 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 12 | suppressed |
| Fenofibric Acid | Fenofibric Acid (Choline) | 12 | suppressed |
| Glipizide | Glipizide | 12 | suppressed |
| Halobetasol Propionate | Halobetasol Propionate | 12 | suppressed |
| Latanoprost | Latanoprost | 12 | suppressed |
| Synthroid | Levothyroxine Sodium | 12 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 12 | suppressed |
| Biktarvy | Bictegrav/Emtricit/Tenofov Ala | 11 | suppressed |
| Hydrocortisone | Hydrocortisone | 11 | suppressed |
| Metronidazole | Metronidazole | 11 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 11 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 11 | suppressed |
| Risperidone | Risperidone | 11 | suppressed |
| Triumeq | Abacavir/Dolutegravir/Lamivudi | 11 | suppressed |
| Valsartan | Valsartan | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $17.63 · 1 records | Sumitomo Pharma America, Inc. | GEMTESA | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error